Considering suitable patients for MART

Considering suitable patients for MART - - Consultant Respiratory Nurse

In this video, June Roberts explains when and why you may consider a MART therapy in line with the NICE guidance and the BTS/SIGN guidelines.1,2 June also discusses how to educate and advise patients about MART therapies.

 

This HCP opinion is not connected, or specific, to Chiesi products.

Talk to us

Request a call or meeting with your local Chiesi representative at a time which suits you.

Request now

Order training inhalers

Support your patients with their inhaler technique by ordering placebo training inhalers directly from Chiesi.

Order now

Sign up for updates

Want to hear more from Chiesi? Opt-in to receive updates on Chiesi Air products and services.

Sign up
UK-RES-2102745 - May 2022

References

    1. National Institute for Health and Care Excellence (NICE). Asthma: diagnosis, monitoring and chronic asthma management 2017. Last updated March 2021. Available at: https://www.nice.org.uk/guidance/ng80/chapter/Recommendations
    2. British Thoracic Society (BTS). BTS/SIGN British Guideline on the Management of Asthma 2019. Available at: https://www.brit-thoracic.org.uk/quality-improvement/guidelines/asthma/

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Limited on 0800 0092329 (UK) or PV.UK@Chiesi.com.